Daniel P Wickland
Overview
Explore the profile of Daniel P Wickland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Sarangi V, Wickland D, Li S, Chen D, Thompson E, et al.
Expert Syst Appl
. 2024 Dec;
262.
PMID: 39676894
Artificial neural networks have recently gained significant attention in biomedical research. However, their utility in survival analysis still faces many challenges. In addition to designing models for high accuracy, it...
2.
Wickland D, McNinch C, Jessen E, Necela B, Shreeder B, Lin Y, et al.
J Immunother Cancer
. 2024 May;
12(5).
PMID: 38754917
Background: Cancer neoantigens arise from protein-altering somatic mutations in tumor and rank among the most promising next-generation immuno-oncology agents when used in combination with immune checkpoint inhibitors. We previously developed...
3.
Kouri N, Frankenhauser I, Peng Z, Labuzan S, Boon B, Moloney C, et al.
JAMA Neurol
. 2024 Apr;
81(6):619-629.
PMID: 38619853
Importance: Factors associated with clinical heterogeneity in Alzheimer disease (AD) lay along a continuum hypothesized to associate with tangle distribution and are relevant for understanding glial activation considerations in therapeutic...
4.
Kase A, Gleba J, Miller J, Miller E, Petit J, Barrett M, et al.
Mol Cancer Ther
. 2024 Mar;
23(6):823-835.
PMID: 38442920
Metastatic castration-resistant prostate cancer (mCRPC) is an aggressive malignancy with poor outcomes. To investigate novel therapeutic strategies, we characterized three new metastatic prostate cancer patient derived-tumor xenograft (PDTX) models and...
5.
Liu X, Wickland D, Lin Z, Liu Q, Dos Santos L, Hudson K, et al.
J Exp Bot
. 2023 Aug;
74(17):5153-5165.
PMID: 37551820
Height is a critical component of plant architecture, significantly affecting crop yield. The genetic basis of this trait in soybean remains unclear. In this study, we report the characterization of...
6.
Matchett B, Lincoln S, Baker M, Tamvaka N, Labuzan S, Hicks Sirmans T, et al.
Medicine (Baltimore)
. 2023 Jun;
102(24):e34017.
PMID: 37327267
We previously demonstrated that increased expression of the SERPINA5 gene is associated with hippocampal vulnerability in Alzheimer's disease (AD) brains. SERPINA5 was further demonstrated to be a novel tau-binding partner...
7.
Wickland D, Sherman M, Radisky D, Mansfield A, Asmann Y
J Natl Cancer Inst
. 2022 Jul;
114(12):1729-1730.
PMID: 35801929
No abstract available.
8.
Wickland D, Sherman M, Radisky D, Mansfield A, Asmann Y
J Natl Cancer Inst
. 2022 Mar;
114(8):1192-1199.
PMID: 35299252
Background: In the United States, cancer disproportionately impacts Black and African American individuals. Identifying genetic factors underlying cancer disparities has been an important research focus and requires data that are...
9.
Wickland D, Ren Y, Sinnwell J, Reddy J, Pottier C, Sarangi V, et al.
PLoS One
. 2021 Apr;
16(4):e0249305.
PMID: 33861770
Genetic studies have shifted to sequencing-based rare variants discovery after decades of success in identifying common disease variants by Genome-Wide Association Studies using Single Nucleotide Polymorphism chips. Sequencing-based studies require...
10.
Ogony J, Radisky D, Ruddy K, Goodison S, Wickland D, Egan K, et al.
Cancer Prev Res (Phila)
. 2020 Aug;
13(11):901-910.
PMID: 32753376
The etiology of triple-negative breast cancers (TNBC) is poorly understood. As many TNBCs develop prior to the initiation of breast cancer screening or at younger ages when the sensitivity of...